Acadia Pharma (ACAD) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Acadia Pharma (ACAD) Tops Q3 EPS by 1c

Acadia Pharmaceuticals (ACAD) Bullish Stance Reiterated at Cowen; All Eyes on PDP PDUFA, ADP Enrollment

November 6, 2015 12:00 PM EST

Cowen analyst Ritu Baral reiterated an Outperform rating and $50 price target on Acadia Pharmaceuticals (NASDAQ: ACAD) following Q3 results with all eyes on PDP PDUFA and ADP enrollment.

Baral commented, "ACAD reported 3Q15 earnings and elaborated on initial steps for upcoming commercial... More

Piper Jaffray Downgrades Acadia Pharmaceuticals (ACAD) to Neutral

November 6, 2015 9:43 AM EST

Piper Jaffray downgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Overweight to Neutral with a price target of $39.00 (from $48.00).

Analyst Charles Duncan commented, "We're downgrading to Neutral following program updates that lower our conviction on near-term upside from the pima pipeline. New concerns center on a... More